Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-07-14
1988-09-20
Rizzo, Nicholas S.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544267, 544273, C07D23936, A61K 3152
Patent
active
047726075
ABSTRACT:
The present invention is various novel diallyl analogs of xanthine. Additionally, the invention is pharmaceutical compositions having as the active compound diallyl analogs of xanthines and methods of use therefor. Processes of preparation of diallyl analogs of xanthine are also the invention. The use of the analogs relates particularly to a desirable affinity at adenosine receptors, particularly the A.sub.1 receptor. The analogs are adenosine receptor antagonists. The analogs, thus, for example provide activity for use as a CNS stimultant cognition activator, antifibrillatory agent, and bronchodilator.
REFERENCES:
patent: 3624215 (1971-11-01), Skokie
patent: 3624216 (1971-11-01), Skokie
patent: 4089959 (1978-05-01), Diamond
patent: 4364922 (1981-12-01), Berne et al.
patent: 4452788 (1984-06-01), Bristol et al.
patent: 4469698 (1984-09-01), Ohilippossian
patent: 4593095 (1986-06-01), Snyder et al.
Schwabe, Pharmacol., vol. 330, pp. 212-221 (1985).
Jacobsen, J. Med. Chem., vol. 28, pp. 1334-1340 (1985).
Hamilton et al., J. Med. Chem., vol. 28, pp. 1071-1079, (1985).
Daly et al., J. Med. Chem., vol. 28, pp. 487-492 (1985).
Badger Edward W.
Hamilton Harriet W.
Rizzo Nicholas S.
Thierstein Joan
Warner-Lambert & Company
LandOfFree
Dialkenyl derivatives of xanthine, pharmaceutical compositions a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dialkenyl derivatives of xanthine, pharmaceutical compositions a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dialkenyl derivatives of xanthine, pharmaceutical compositions a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1748748